U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Hartley Medical Center Pharmacy, Incorporated - 483574 - 09/26/2017
  1. Warning Letters

CLOSEOUT LETTER

Hartley Medical Center Pharmacy, Incorporated MARCS-CMS 483574 —

Recipient:
Hartley Medical Center Pharmacy, Incorporated

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

Division of Pharmaceutical Quality Operations IV
19701 Fairchild Road
Los Angeles, California 92612
Telephone: (949) 608-2900
Fax: (949) 608-4415 
 
 

VIA UNITED PARCEL SERVICE

September 26, 2017

William Stuart, Owner/President
Hartley Medical Center Pharmacy, Inc.
113 W. Victoria Street
Long Beach, CA 90805-2162

Dear Mr. Stuart:

The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [WL #29-16] dated April 21, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Acting for CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV
 

Back to Top